<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02857855</url>
  </required_header>
  <id_info>
    <org_study_id>1WB/1/23/06/2016</org_study_id>
    <nct_id>NCT02857855</nct_id>
  </id_info>
  <brief_title>Postoperative Supplemental Oxygen in Liver Transplantation</brief_title>
  <acronym>PSOLT</acronym>
  <official_title>The Impact of Postoperative Oxygen Therapy on the Results of Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective randomized controlled trial is to evaluate the impact of high
      concentration supplemental postoperative oxygen therapy on short-term and long-term results
      of liver transplantation, particularly with respect to infections and biliary complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this prospective randomized controlled trial is to evaluate the impact of high
      concentration supplemental postoperative oxygen therapy on short-term and long-term results
      of liver transplantation, particularly with respect to infections and biliary complications.
      A total of 296 patients immediately after liver transplantation will be randomly assigned to
      receive either 80% (high concentration) or 28% (controls) fraction of inspired oxygen for 6
      hours after surgery with a 1:1 allocation ratio. Patients will be blinded to the type of
      received intervention. Randomization will be stratified by the Child-Turcotte-Pugh
      classification. Both groups will be compared to short- and long-term outcome measures.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with postoperative infections</measure>
    <time_frame>30 days</time_frame>
    <description>Occurrence of postoperative infection defined according to the Centers for Disease Control and Prevention (Am J Infect Control 2008; 36: 309-32)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biliary complications</measure>
    <time_frame>5 years</time_frame>
    <description>Biliary complications requiring endoscopic, percutaneous or surgical intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative mortality</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe postoperative complications</measure>
    <time_frame>90 days</time_frame>
    <description>&gt;= grade 3 according to Clavien-Dindo classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient survival</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft survival</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital stay</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative intensive care unit stay</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum aspartate aminotransferase activity</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum alanine aminotransferase activity</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum bilirubin concentration</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International normalized ratio</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early allograft dysfunction</measure>
    <time_frame>7 days</time_frame>
    <description>One or more of the following: bilirubin &gt;or=10mg/dL on postoperative day 7, international normalized ratio &gt;or=1.6 on postoperative day 7, alanine or aspartate aminotransferases &gt;2000 IU/L within the first postoperative 7 days (Olthoff et al, Liver Transpl 2010; 16: 943-9)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary complications</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">296</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>80% fraction of inspired oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>80% fraction of inspired oxygen delivered either by a nonrebreathing facemask with a reservoir with oxygen flow of 14 l/min and air flow of 2 l/min or by a respirator for first 6 postoperative hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>28% fraction of inspired oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>28% fraction of inspired oxygen delivered either by a Venturi facemask or by a respirator for first 6 postoperative hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>80% fraction of inspired oxygen for 6 postoperative hours</intervention_name>
    <description>80% fraction of inspired oxygen delivered for 6 postoperative hours, either by a nonrebreathing facemask with a reservoir or by a respirator</description>
    <arm_group_label>80% fraction of inspired oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>28% fraction of inspired oxygen for 6 postoperative hours</intervention_name>
    <description>28% fraction of inspired oxygen delivered for 6 postoperative hours, either by a Venturi facemask or by a respirator</description>
    <arm_group_label>28% fraction of inspired oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  active liver transplant waitlist status

        Exclusion Criteria:

          -  active infection at the time of transplantation

          -  malignancy

          -  cardiac arrest during transplantation

          -  chronic obstructive pulmonary disease

          -  acute myocardial infarction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michał Grąt, M.D., PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of General, Transplant and Liver Surgery, Medical University of Warsaw</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of General, Transplant and Liver Surgery, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <state>Mazowieckie</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2016</study_first_posted>
  <last_update_submitted>August 2, 2016</last_update_submitted>
  <last_update_submitted_qc>August 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver transplantation</keyword>
  <keyword>postoperative infection</keyword>
  <keyword>biliary complications</keyword>
  <keyword>patient survival</keyword>
  <keyword>graft survival</keyword>
  <keyword>supplemental oxygen</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

